Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Filings indexed 250 across all filing types
Latest filing 2023-10-26 Director's Dealing
Country KR South Korea
Listing KO 304840

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed by an individual (Kim Shin-won) regarding their holdings in PeopleBio. This is a standard regulatory filing in South Korea (DART system) used to report insider transactions and changes in share ownership by directors or major shareholders. This falls under the 'Director's Dealing' category.
2023-10-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a specific executive (Kang Sungmin) of PeopleBio, including dates of acquisition and the nature of the transactions (e.g., capital increase). This is a standard regulatory filing for insider shareholding changes, which corresponds to the 'Director's Dealing' category.
2023-10-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (often referred to as a 5% report or major shareholding notification). It details changes in share ownership, including acquisitions through rights offerings and bonus issues, and lists the reporting person and special related parties. This fits the definition of a Major Shareholding Notification (MRQ).
2023-10-26 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자) for the company PeopleBio. It provides specific details such as the reference price and the effective date. This type of corporate action announcement regarding capital changes fits the 'Share Issue/Capital Change' category.
2023-10-20 Korean
증권발행실적보고서
Share Issue/Capital Change Classification · 100% confidence The document is a '증권발행실적보고서' (Report on the Results of Securities Issuance) filed with the Financial Supervisory Service (FSS) in South Korea. It details the final results of a capital increase (rights offering), including subscription status, allocation, use of proceeds, and changes in major shareholdings. This document is a standard regulatory filing required after the completion of a capital raising event. Given the specific nature of reporting the results of a securities issuance, it falls under the 'Share Issue/Capital Change' category.
2023-10-19 Korean
증권발행결과(자율공시)(주주배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement titled '증권 발행결과' (Securities Issuance Results) regarding a capital increase (유상증자) by PeopleBio. It details the number of shares issued, the total amount raised, and the payment completion date. This falls under the category of share issuance and capital changes.
2023-10-19 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.